These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7792869)

  • 1. Evaluation of the development of bronchiolitis obliterans syndrome in single lung recipients by assessment of transplant FEV1 with 133-XE radiospirometry.
    Ikonen T; Harjula AL; Kinnula V; Savola J; Sovijärvi AR
    Transplant Proc; 1995 Jun; 27(3):2008. PubMed ID: 7792869
    [No Abstract]   [Full Text] [Related]  

  • 2. Assessment of forced expiratory volume in one second-fraction of the engrafted lung with 133-Xe radiospirometry improves the diagnosis of bronchiolitis obliterans syndrome in single lung transplant recipients.
    Ikonen T; Harjula AL; Kinnula VL; Savola J; Sovijärvi A
    J Heart Lung Transplant; 1995; 14(2):244-50. PubMed ID: 7779842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of FEV1 fraction of the transplant and the native lung with 133Xe radiospirometry after single lung transplantation.
    Ikonen T; Harjula A; Savola J; Mattila S; Sovijärvi A
    Transplant Proc; 1995 Dec; 27(6):3488. PubMed ID: 8540062
    [No Abstract]   [Full Text] [Related]  

  • 4. Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Dusmet M; Maurer J; Winton T; Kesten S
    J Heart Lung Transplant; 1996 Sep; 15(9):948-54. PubMed ID: 8889991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Post-transplant baseline FEV1 and the development of bronchiolitis obliterans syndrome: an important confounder?
    Burton CM; Iversen M; Mortensen J; Carlsen J; Andersen CB; Milman N; Scheike T
    J Heart Lung Transplant; 2007 Nov; 26(11):1127-34. PubMed ID: 18022078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/bronchitis in pulmonary allografts.
    Ross DJ; Marchevsky A; Kramer M; Kass RM
    J Heart Lung Transplant; 1997 Aug; 16(8):832-8. PubMed ID: 9286775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in induced sputum in the presence of bronchiolitis obliterans syndrome and correlation with spirometry in single and bilateral lung transplant recipients.
    Allen DJ; Fildes JE; Yonan N; Leonard CT
    J Heart Lung Transplant; 2005 Jan; 24(1):88-91. PubMed ID: 15653385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation.
    Davis RD; Lau CL; Eubanks S; Messier RH; Hadjiliadis D; Steele MP; Palmer SM
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):533-42. PubMed ID: 12658195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
    Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
    J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation.
    Walter JN; Fan LL; Bag R; Zhang H; Doan M; Mallory GB; Elidemir O
    Transplantation; 2006 Sep; 82(5):709-11. PubMed ID: 16969297
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seasonal onset of bronchiolitis obliterans syndrome in lung transplant recipients.
    Hohlfeld J; Niedermeyer J; Hamm H; Schäfers HJ; Wagner TO; Fabel H
    J Heart Lung Transplant; 1996 Sep; 15(9):888-94. PubMed ID: 8889984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of mean transit time in the engrafted lung with 133Xe lung ventilation scintigraphy improves diagnosis of bronchiolitis obliterans syndrome in living-donor lobar lung transplant recipients.
    Shinya T; Sato S; Kato K; Gobara H; Akaki S; Date H; Kanazawa S
    Ann Nucl Med; 2008 Jan; 22(1):31-9. PubMed ID: 18250985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obstructive flow-volume loop contours after single lung transplantation.
    Ross DJ; Belman MJ; Mohsenifar Z; Nathan SD; Kass RM; Koerner SK
    J Heart Lung Transplant; 1994; 13(3):508-13. PubMed ID: 8061028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of transbronchial lung biopsy specimens in the diagnosis of bronchiolitis obliterans after lung transplantation.
    Chamberlain D; Maurer J; Chaparro C; Idolor L
    J Heart Lung Transplant; 1994; 13(6):963-71. PubMed ID: 7865530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of D-dimer in lung transplant recipients with bronchiolitis obliterans syndrome.
    Shitrit D; Amital A; Fox B; Kramer MR
    Respir Med; 2008 Feb; 102(2):205-9. PubMed ID: 17976973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study.
    Gerhardt SG; McDyer JF; Girgis RE; Conte JV; Yang SC; Orens JB
    Am J Respir Crit Care Med; 2003 Jul; 168(1):121-5. PubMed ID: 12672648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis.
    Valentine VG; Robbins RC; Berry GJ; Patel HR; Reichenspurner H; Reitz BA; Theodore J
    J Heart Lung Transplant; 1996 Apr; 15(4):371-83. PubMed ID: 8732596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma C-reactive protein levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
    Vos R; Vanaudenaerde BM; De Vleeschauwer SI; Van Raemdonck DE; Dupont LJ; Verleden GM
    Transplant Proc; 2009 Mar; 41(2):595-8. PubMed ID: 19328934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung Transplant Patients Show a Dissimilar Peripheral B-Cell Subset Ratio Compared With Healthy Controls.
    Schreurs I; Meek B; Hijdra D; Rodriguez Gomez M; van Moorsel CHM; Luijk HD; Kwakkel-van Erp JM; Oudijk EJ; van Kessel DA; Grutters JC
    Exp Clin Transplant; 2020 Apr; 18(2):234-241. PubMed ID: 32279657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hidden Markov models for the onset and progression of bronchiolitis obliterans syndrome in lung transplant recipients.
    Jackson CH; Sharples LD
    Stat Med; 2002 Jan; 21(1):113-28. PubMed ID: 11782054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.